ES524896A0 - Procedimiento para obtener un polipeptido con efecto sobre el sistema de inmunidad - Google Patents

Procedimiento para obtener un polipeptido con efecto sobre el sistema de inmunidad

Info

Publication number
ES524896A0
ES524896A0 ES524896A ES524896A ES524896A0 ES 524896 A0 ES524896 A0 ES 524896A0 ES 524896 A ES524896 A ES 524896A ES 524896 A ES524896 A ES 524896A ES 524896 A0 ES524896 A0 ES 524896A0
Authority
ES
Spain
Prior art keywords
polypeptide
procedure
obtaining
effect
immunity system
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES524896A
Other languages
English (en)
Other versions
ES8404514A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Publication of ES524896A0 publication Critical patent/ES524896A0/es
Publication of ES8404514A1 publication Critical patent/ES8404514A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/26—Lymph; Lymph nodes; Thymus; Spleen; Splenocytes; Thymocytes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/837—Lymph; lymph-glands; thymus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/838—Marrow; spleen
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/854—Glands

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Detergent Compositions (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Polyamides (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ES524896A 1982-08-13 1983-08-11 Procedimiento para obtener un polipeptido con efecto sobre el sistema de inmunidad Expired ES8404514A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3230151A DE3230151A1 (de) 1982-08-13 1982-08-13 Neues polypeptid mit wirkung auf das immunsystem, verfahren zu seiner isolierung und reinigung, seine verwendung, dieses enthaltende mittel sowie seine spaltprodukte, deren verwendung und diese enthaltende mittel

Publications (2)

Publication Number Publication Date
ES524896A0 true ES524896A0 (es) 1984-05-01
ES8404514A1 ES8404514A1 (es) 1984-05-01

Family

ID=6170793

Family Applications (1)

Application Number Title Priority Date Filing Date
ES524896A Expired ES8404514A1 (es) 1982-08-13 1983-08-11 Procedimiento para obtener un polipeptido con efecto sobre el sistema de inmunidad

Country Status (13)

Country Link
US (2) US4500450A (es)
EP (1) EP0101063B1 (es)
JP (1) JPS5948422A (es)
KR (1) KR840005665A (es)
AT (1) ATE51628T1 (es)
AU (1) AU566133B2 (es)
CA (1) CA1232218A (es)
DE (2) DE3230151A1 (es)
DK (1) DK366783A (es)
ES (1) ES8404514A1 (es)
IL (1) IL69475A (es)
NO (1) NO163959C (es)
ZA (1) ZA835951B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0149468B1 (de) * 1984-01-12 1990-10-31 SYMBIOTEC Gesellschaft zur Forschung und Entwicklung auf dem Gebiet der Biotechnologie GmbH Biologisch wirksame Substanz mit hormonellen Eigenschaften, Verfahren zu ihrer Herstellung und Verwendung von Histonen für medizinische Zwecke
US4595588A (en) * 1984-05-24 1986-06-17 Board Of Regents, The University Of Texas System Natural inhibitor that protects against viral infections
AU602483B2 (en) * 1985-01-18 1990-10-18 Immunetech Pharmaceuticals Immunoregulatory peptides
US5817753A (en) * 1985-12-04 1998-10-06 The Ohio State University Research Foundation Antigenic modification of polypeptides
FR2594847B1 (fr) * 1986-02-25 1989-06-02 Moet Hennessy Rech Procede de preparation de polypeptides biologiquement actifs, polypeptides obtenus et compositions les contenant
IT1196958B (it) * 1986-07-10 1988-11-25 Ellem Ind Farmaceutica Derivato di timo attivo per via orale, procedimenti per la sua preparazione e relative composizioni farmaceutiche
IT1217314B (it) * 1987-02-20 1990-03-22 Sclavo Spa Nonapeptide sintetico ad attivita'adiuvante capace di potenziare in vivo la risposta anticorporale
US5807830A (en) * 1987-12-30 1998-09-15 Cytoven J.V. Method for treatment of purulent inflammatory diseases
US5728680A (en) 1987-12-30 1998-03-17 Cytoven J.V. Methods for normalizing numbers of lymphocytes
US5110600A (en) * 1988-01-25 1992-05-05 The Regents Of The University Of California Method of treating viral infections with amino acid analogs
US5811399A (en) * 1988-12-14 1998-09-22 Cytran, Inc. Pharmaceutical dipeptide compositions and methods of use thereof: immunodepressants
US5770576A (en) * 1989-08-30 1998-06-23 Cytran, Inc. Pharmaceutical dipeptide compositions and methods of use thereof: systemic toxicity
US6100380A (en) * 1991-10-28 2000-08-08 Cytran, Inc. Immunomodulating peptides and methods of use
US6066622A (en) 1991-10-28 2000-05-23 Cytran, Inc. Immunomodulating peptides and methods of use
US6458761B2 (en) * 1999-11-24 2002-10-01 Lore Maria Klett-Loch Synthetic, statistic thymic peptide combination and its use as a preparation with immunological and/or endocrinological effect

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4077949A (en) * 1973-12-28 1978-03-07 Sloan-Kettering Institute For Cancer Research Polypeptide hormones of the thymus
US4002602A (en) * 1974-03-11 1977-01-11 Gideon Goldstein Ubiquitous immunopoietic polypeptide (UBIP) and methods
US4010148A (en) * 1975-05-12 1977-03-01 Board Of Regents Of The University Of Texas System Purified thymosin and process
IL47645A (en) * 1975-07-04 1980-10-26 Yeda Res & Dev Substantially pure and uniform thymic hormone thf,its preparation and pharmaceutical compositions containing it
US4120951A (en) * 1975-08-22 1978-10-17 Sloan-Kettering Institute For Cancer Research Polypeptide hormones of the thymus
US4055633A (en) * 1976-07-28 1977-10-25 Sloan-Kettering Institute For Cancer Research Immunoassay for thymopoietin
US4079127A (en) * 1976-10-28 1978-03-14 Board Of Regents Of The University Of Texas Thymosin alpha 1
US4297276A (en) * 1979-03-23 1981-10-27 Hoffman-La Roche Inc. Thymosin beta 3 and beta 4
US4261886A (en) * 1980-03-13 1981-04-14 Ortho Pharmaceutical Corporation Peptides having thymopoietin-like activity
EP0033384B1 (de) * 1980-01-18 1984-02-15 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Thymosin-alpha-1-Fragmente enthaltende Arzneimittel mit immunstimulierender Wirkung, und Thymosin-alpha-1-Fragmente
FR2492663B1 (fr) * 1980-10-24 1985-11-08 Vtoroi Mo G Produit medicamenteux regulateur du t-systeme de l'immunite et son procede de preparation
US4389343A (en) * 1981-12-24 1983-06-21 Hoffmann-La Roche Inc. Immunopotentiating peptides from thymus
US4388234A (en) * 1981-12-28 1983-06-14 Hoffmann-La Roche Inc. Peptide isolation
US4395404A (en) * 1982-05-14 1983-07-26 George Washington University Synthetic thymosin β3 and β4 analogues

Also Published As

Publication number Publication date
NO163959C (no) 1990-08-15
ATE51628T1 (de) 1990-04-15
AU566133B2 (en) 1987-10-08
AU1795783A (en) 1984-02-16
DK366783A (da) 1984-02-14
DE3381410D1 (de) 1990-05-10
ES8404514A1 (es) 1984-05-01
DE3230151A1 (de) 1984-02-16
NO163959B (no) 1990-05-07
NO832904L (no) 1984-02-14
US4500450A (en) 1985-02-19
ZA835951B (en) 1984-04-25
CA1232218A (en) 1988-02-02
EP0101063A2 (de) 1984-02-22
KR840005665A (ko) 1984-11-16
EP0101063A3 (en) 1986-05-14
DK366783D0 (da) 1983-08-11
EP0101063B1 (de) 1990-04-04
IL69475A (en) 1986-10-31
JPS5948422A (ja) 1984-03-19
US4526717A (en) 1985-07-02

Similar Documents

Publication Publication Date Title
IL69475A (en) Polypeptide having an action on the immunological system,processes for its isolation and purification,its protease cleavage products and pharmaceutical compositions containing them
PT883687E (pt) Receptores de quimiocinas c-c, ckr-5, cc, os seus derivados e as suas utilizacoes
ES538849A0 (es) Aparato para evaluar el rendimiento de por lo menos un sistema de funcionamiento
ATE81135T1 (de) Aktive thymopentin-analoga.
ES510134A0 (es) Levitacionario para la flotacion de seres humanos en el aire.
BR8707563A (pt) Sistema de propulsao para uma aeronave
ES513613A0 (es) "procedimiento e instalacion para el clivado de material, en particular material esquistoso".
ES251202Y (es) Dispositivo de valvula para el cierre de botellas.
ES2185628T3 (es) Procedimiento para preparar proteinas modificadas.
ES493034A0 (es) Mejoras introducidas en el objeto de la patente principal n.459766:sobre sistema para herrar caballos.
ES536142A0 (es) Instalacion para le tratamiento mecanico de los bajos buque en el dique.
ES511760A0 (es) Procedimiento para eliminar el grupo n-formilo de peptidos n-formilo de peptidos n-formilados o de esteres de peptidos n-formilados.
ES513692A0 (es) "perfeccionamientos en los sistemas de mantener el contenido de aire en instalaciones de bombeo".
ES2023962B3 (es) Sistema para convertir residuos en inocuos para el ambiente.
ES553797A0 (es) Procedimiento para el aseguramiento de la separacion de corrientes de gas de atmosfera diferente e instalacion para la realizacion del mismo
ES1000064Y (es) Dispositivo para el descorchado de botellas de champan
ES499333A0 (es) Perfeccionamientos introducidos en el sistema locomotor de los vehiculos todo terreno
MX151630A (es) Mejoras en sistema de extension para mesas de servicio o similares
IT1201267B (it) Un agente che favorisce l'erezione e la fecondita' un metodo per produrre tale agente ad impiego dell'agente stesso nella produzione di composizioni che favoriscono l'erezione e la fecondita'
ITRM920177A1 (it) Sistema di armamento ferroviario del tipo senza massicciata.
ES502291A0 (es) Proceso para el acondicionamiento de los sensores de tipo semiconductor en alcoholimetros
ES525590A0 (es) Mejoras introducidas en el objeto de la patente principal n 478.537,presentada el 120379,por:mejoras introducidas en el sistema de carga de buques de la clase frigorifica
GR1001409B (el) Ενώσεις για την ?εραπευτική αγωγή ασ?ενειών που έχουν σχέση με λευκοτριένια.
ES1004221Y (es) Perfeccionamientos en el sistema de seguridad para bidones
IT8511845V0 (it) Ampliamento del sistema di vendita per corrispondenza,servizio doni

Legal Events

Date Code Title Description
MM4A Patent lapsed

Effective date: 19960506